Post Marketing Clinical (PMC) PDF
Phase IV Studies – A Market With A Proactive Approach For Growth Of A Pharmaceutical Business
 
Summary
 
Phase IV studies are required as a condition of market approval. The companies look at venturing into Post marketing studies to improve the potential of the marketed product. This
Phase has been the fastest growing segment in the area of clinical research. It supports in finding data for newer indications and new markets for which the drug product had not been
initially approved. These studies should be randomized1 and to maximize the informational value. The Phase IV research environment is driven by the varying regulatory environment,
increasing safety concerns of new medicines, and the need for real-world data on the marketed drugs. This paper gives an overview of the Phase IV studies which form an integral part of the drug evaluation process and is a promising phase of advancement in the area of marketed drugs.
 
 

News

Vaccine Industry in India – An Emerging Global Hub

Asia is emerging as the vaccine hub of the world and India is on the go to play a key role in the...

RECOGNITIONS

“G7 SYNERGON has been recognized by the Department of Scientific and Industrial Research (D...

CHRONICLE PHARMABIZ

India, an emerging global hub for vaccine industry ASIA is emerging as the vaccine hub ...

Post Marketing Clinical (PMC)

Phase IV Studies – A Market With A Proactive Approach For Growth Of A Pharmaceutical Busine...
Counter :mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter

© 2019 G7 SYNERGON. All rights Reserved